Regeneron Pharmaceuticals, Inc.

Skandinaviska Enskilda Banken AB (publ) REGN

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/12/2026

Shares

56,619

Value ($000)

43,710

Weight

0.2%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/12/2026	43,710	0.2%	56,619	12/31/2025
2025 Q3	11/7/2025	32,010	0.1%	56,974	9/30/2025
2025 Q2	8/13/2025	35,757	0.2%	68,140	6/30/2025
2025 Q1	5/7/2025	43,183	0.2%	68,140	3/31/2025
2024 Q4	2/10/2025	47,994	0.2%	68,328	12/31/2024
2024 Q3	11/7/2024	79,006	0.4%	75,216	9/30/2024
2024 Q2	8/13/2024	77,580	0.4%	73,808	6/30/2024
2024 Q1	5/13/2024	71,142	0.3%	73,954	3/31/2024
2023 Q4	2/14/2024	66,717	0.4%	75,927	12/31/2023
2023 Q3	11/9/2023	62,886	0.4%	76,414	9/30/2023
2023 Q2	8/7/2023	71,807	0.5%	99,935	6/30/2023
2023 Q1	5/11/2023	73,468	0.5%	89,413	3/31/2023
2022 Q4	2/8/2023	72,376	0.5%	100,314	12/31/2022
2022 Q3	11/14/2022	86,251	0.7%	125,207	9/30/2022
2022 Q2	8/10/2022	66,234	0.5%	112,046	6/30/2022
2022 Q1	5/11/2022	107,051	0.6%	153,276	3/31/2022
2021 Q4	2/10/2022	128,264	0.7%	199,630	12/31/2021
2021 Q3	11/10/2021	65,758	0.4%	108,659	9/30/2021
2021 Q2	8/10/2021	31,188	0.2%	55,838	6/30/2021
2021 Q1	5/14/2021	39,663	0.3%	83,829	3/31/2021
2020 Q4	2/11/2021	55,986	0.4%	115,887	12/31/2020
2020 Q3	11/12/2020	58,289	0.4%	104,128	9/30/2020
2020 Q2	8/13/2020	61,383	0.5%	98,425	6/30/2020
2020 Q1	5/13/2020	57,248	0.6%	117,242	3/31/2020
2019 Q4	2/14/2020	55,020	0.4%	146,532	12/31/2019